Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Deoxyribozyme wikipedia , lookup
Genetic code wikipedia , lookup
In vitro fertilisation wikipedia , lookup
Mitochondrial replacement therapy wikipedia , lookup
Biochemistry wikipedia , lookup
Catalytic triad wikipedia , lookup
Cryobiology wikipedia , lookup
Biosynthesis wikipedia , lookup
Impact of aspartate and serine on mouse embryo development in vitro Jaffar 1* Ali and Nafisa 2 Ali 1*Department of Obstet. & Gynaecol, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Email: [email protected]; Tel: +603 7949 6898; Fax: +603 7949 4193 Abstract No. Aspir-0176 2School of Archaeology & Anthropology, ANU College of Arts and Social Sciences, AD Hope Building, The Australian National University, Canberra, ACT 2601, Australia BACKGROUND Attempts to improve in vitro culture conditions of early embryos must determine the nutritional requirement of individual nutrient components that impact embryo development in vitro. The findings of the present research effort is to assist elucidate the effect of two amino acids on embryo development. Amino acids are crucial for protein synthesis, energy metabolism and for its role as osmolytes. Image 1: Human embryo generated in synthetic proteinfree ECM; now a youngster aged about 17 yrs. CONCLUSION Supplementation of both aspartate and serine in embryo culture medium appear detrimental but these effects were insignificant. These responses were obtained under the confounding influences of bovine serum albumin that is present in conventional embryo culture media (ECM). The present findings showed the addition of these two amino acids in conventional ECM containing serum proteins may not be useful and may even be harmful. This suggests the practice of supplementing ECM with aspartate and serine be re-examined. Table 1: Effect of Aspartate on embryo development in vitro Concentration of Aspartate (mM) 0 250 500 750 1000 Day 1 Embryos 79 76 79 77 76 A 15-20 YEARS RESEARCH EFFORT: This study is part of a 15-20 years of research effort to culture embryos in synthetic and chemically defined conditions (Ali, 1997; Ali et al., 2000; Ali, 2007) devoid of added donor serum proteins. Day 2 71 73 75 75 73 Day-3 40 37 48 42 37 Day-4 40 36 48 42 36 OBJECTIVE Day-5 27 26 34 33 27 The objective is to determine the optimal concentrations, tolerance levels and effects of aspartate and serine on mouse embryo development in vitro. Day-6 %Dead r=0.4093 (p=1) p-value Chi-square for trend+ 23 26 33 31 25 29.1 34.2 41.8 40.3 32.9 0.9901 0.8672 0.9318 0.9944 MATERIALS AND METHODS Earleās Basal salt solution was supplemented with 5mg/ml of bovine serum albumin, antibiotics penicillin/ streptomycin sulfate, and pyruvate/ lactate. Treatments consisted of culture media supplemented with graded amounts (0, 250,500,750 and 1000mM) of aspartate and serine. Quakenbush sibling mice zygotes were randomly apportioned to individual treatments. The numbers of replicates were 5 and 4 respectively. The end point was the development of day 6 (expanded, hatching, hatched) embryos. Replicates=5; n= 387 embryos +Treatments compared individually with control Table 2: Effect of Serine on embryo development in vitro Concentration of Serine (mM) Day 1 Embryos RESULTS The proportion of day 6 embryos developed decreased when supplemented with aspartate with the portion of dead increased 29.1, 34.2, 41.8, 40.3, 32.9% with the addition of graded amounts (0, 250,500,750 and 1000mM respectively) of aspartate with maximum effect seen with treatment supplemented with 500mM but this was not significant. Likewise all treatments supplemented with serine resulted in insignificant increases in embryonic death and was harmful at all concentrations tested (%dead: c =51.6, 250mM=58.3%, 500mM=53.3%, 750mM=75% and 1000mM=61.7% respectively; r = 0.6271; p=0.2575). REFERENCE Ali,1997. FSA Annual Conference, Adelaide, Australia Ali et al., 2000, Human Reprod 15:145-156 Ali, 2004, MEFS J. 9(2):118-127 Ali, J. United States Patent US2009/0226879 A1;Dec 2007; PCT 2008 (No. US2009/0226879 A1); (PCT US No. PCT/US2008087818) 0 250 500 750 1000 62 60 60 60 60 57 56 57 55 55 40 36 40 31 31 40 33 33 28 31 39 32 28 24 25 30 25 28 15 23 51.6 58.3 53.3 75 61.7 0.9804 0.8963 0.3382 0.7604 Day 2 Day 3 Day 4 Day 5 Day 6 % dead embryos r = 0.6271 (p=0.2575) P-value; Chi-square for trend+ Replicates = 4; n= 302 embryos +Treatments compared individually with control www.um.edu.my